Rodolfo Delgado-Lezama

Prof. Rodolfo Delgado-Lezama


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Molecular Pain
Verified
Journal Article
Open access
JPJorge Baruch Pineda-Farias
Jorge Baruch Pineda-Farias
PBPaulino Barragan-Iglesias
Paulino Barragan-Iglesias
ELEmanuel Loeza-Alcocer
Emanuel Loeza-Alcocer
JTJorge E Torres-Lopez
Jorge E Torres-Lopez
HRHéctor Isaac Rocha-González
Héctor Isaac Rocha-González
VGVinicio Granados-Soto
Vinicio Granados-Soto
Background: Calcium-activated chloride channels (CaCCs) activation induces membrane depolarization by increasing chloride efflux in primary sensory neurons that can facilitate action potential generation. Previous studies suggest that CaCCs family members bestrophin-1 and anoctamin-1 are involved in inflammatory pain. However, their role in neuropathic pain is unclear. In this investigation we assessed the involvement of these CaCCs family members in rats subjected to the L5/L6 spinal nerve ligation. In addition, anoctamin-1 and bestrophin-1 mRNA and protein expression in dorsal root ganglion (DRG) and spinal cord was also determined in the presence and absence of selective inhibitors.Results: L5/L6 spinal nerve ligation induced mechanical tactile allodynia. Intrathecal administration of non-selective CaCCs inhibitors (NPPB, 9-AC and NFA) dose-dependently reduced tactile allodynia. Intrathecal administration of selective CaCCs inhibitors (T16Ainh-A01 and CaCCinh-A01) also dose-dependently diminished tactile allodynia and thermal hyperalgesia. Anoctamin-1 and bestrophin-1 mRNA and protein were expressed in the dorsal spinal cord and DRG of naïve, sham and neuropathic rats. L5/L6 spinal nerve ligation rose mRNA and protein expression of anoctamin-1, but not bestrophin-1, in the dorsal spinal cord and DRG from day 1 to day 14 after nerve ligation. In addition, repeated administration of CaCCs inhibitors (T16Ainh-A01, CaCCinh-A01 or NFA) or anti-anoctamin-1 antibody prevented spinal nerve ligation-induced rises in anoctamin-1 mRNA and protein expression. Following spinal nerve ligation, the compound action potential generation of putative C fibers increased while selective CaCCs inhibitors (T16Ainh-A01 and CaCCinh-A01) attenuated such increase.Conclusions: There is functional anoctamin-1 and bestrophin-1 expression in rats at sites related to nociceptive processing. Blockade of these CaCCs suppresses compound action potential generation in putative C fibers and lessens established tactile allodynia. As CaCCs activity contributes to neuropathic pain maintenance, selective inhibition of their activity may function as a tool to generate analgesia in nerve injury pain states.

1 June 2013 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
RDRodolfo Delgado-Lezama
Rodolfo Delgado-Lezama
ELEmanuel Loeza-Alcocer
Emanuel Loeza-Alcocer
CACarmen Andres
Carmen Andres
JAJusto Aguilar
Justo Aguilar
PGPierre Guertin
Pierre Guertin
RFRicardo Felix
Ricardo Felix
γ-aminobutyric acid (GABA) plays many of its key roles in embryonic development and functioning of the central nervous system (CNS) by acting on ligand gated chloride-permeable channels known as GABAA receptors (GABAAR). Classically, GABAARmediated synaptic communication is tailored to allow rapid and precise transmission of information to synchronize the activity of large populations of cells to generate and maintain neuronal networks oscillations. An alternative type of inhibition mediated by GABAA receptors, initially described about 25 years ago, is characterized by a tonic activation of receptors that react to ambient extracellular GABA. The receptors that mediate this action are wide-spread throughout the nerve cells but are located distant from the sites of GABA release, and therefore they have been called extrasynaptic GABAA receptors. The molecular nature of the extrasynaptic GABAA receptors and the tonic inhibitory current they generate have been characterized in many brain structures, and due to its relevance in controlling neuron excitability they have become attractive pharmacological targets for a variety of neurological disorders such as schizophrenia, epilepsy and Parkinson disease. In the spinal cord, early studies have implicated these receptors in anesthesia, chronic pain, motor control, and locomotion. This review highlights past and present developments in the field of extrasynaptic GABAA receptors and emphasizes their subunit containing distribution and physiological role in the spinal cord.

1 January 2004 in Journal of Neurophysiology
Verified
Journal Article
Closed access
RDRodolfo Delgado-Lezama
Rodolfo Delgado-Lezama
JAJusto Aguilar
Justo Aguilar
RCRafael Cueva-Rolón
Rafael Cueva-Rolón
The role of GABAA and GABAB receptors in modulation of excitatory synaptic transmission between motoneurons and terminals from dorsolateral funiculus (DLF) was studied in in vitro spinal cord slices of adult turtles. Muscimol—a GABAA receptor agonist— depressed the monosynaptic excitatory postsynaptic potential (EPSP) induced by stimulation of the DLF and shortened its duration. The input resistance and the membrane time constant also were strongly reduced. The input membrane resistance, the amplitude, and the half-width of the EPSP were reduced at the same rate in the presence of muscimol. Bicuculline—a GABAA receptor antagonist—increased the EPSPs amplitude and the input membrane resistance. The EPSP amplitude ratio elicited by a paired-pulse protocol did not change significantly. Our results suggest that muscimol acts mainly by activation of postsynaptic GABAA receptors located on the motoneuron and the synaptic strength on motoneurons may be modulated by tonic activation of postsynaptic GABAA receptors. Baclofen—a GABAB receptor agonist—also depressed DLF-motoneuron synaptic transmission. However, it did not affect the falling phase of the EPSPs or the motoneuron membrane time constant but induced a small decrement in input resistance. In the presence of baclofen, the amplitude ratio produced by a paired-pulse protocol increased significantly. This suggests that baclofen decreased the synaptic strength by inhibition of neurotransmitter release from the DLF terminals via activation of presynaptic GABAB receptors.

15 July 2010 in The Journal of Physiology
Verified
Journal Article
Closed access
WBWendy Bautista
Wendy Bautista
JAJusto Aguilar
Justo Aguilar
JLJosé Emanuel Loeza‐Alcocer
José Emanuel Loeza‐Alcocer
RDRodolfo Delgado-Lezama
Rodolfo Delgado-Lezama

1 September 2021 in Neuroscience Research
Verified
Journal Article
Closed access
AVAlberto Vargas-Parada
Alberto Vargas-Parada
ELEmanuel Loeza-Alcocer
Emanuel Loeza-Alcocer
RGRicardo González-Ramírez
Ricardo González-Ramírez
MRMarina Rodríguez-Sánchez
Marina Rodríguez-Sánchez
GRGuadalupe Raya-Tafolla
Guadalupe Raya-Tafolla
RDRodolfo Delgado-Lezama
Rodolfo Delgado-Lezama

19 August 2021 in Physiological Reports
Verified
Journal Article
Open access
PDF file
RDRodolfo Delgado‐Lezama
Rodolfo Delgado‐Lezama
MBMariana Bravo‐Hernández
Mariana Bravo‐Hernández
ÚFÚrzula Franco‐Enzástiga
Úrzula Franco‐Enzástiga
YLYarim E. De la Luz‐Cuellar
Yarim E. De la Luz‐Cuellar
NANara S. Alvarado‐Cervantes
Nara S. Alvarado‐Cervantes
VGVinicio Granados-Soto
Vinicio Granados-Soto
The extrasynaptic α5GABAARs expressed in the dorsal horn spinal cord neurons mediate mechanical allodynia in various models of chronic pain. The extrasynaptic α5GABAARs have an antinociceptive and pr...